Some of the articles in vascular liver diseases in April-May 2018

Home Forums Valdig.eu website Some of the articles in vascular liver diseases in April-May 2018

  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #1972
      Akash Shukla
      Participant

      1. Doppler ultrasound in the diagnosis of Budd-Chiari syndrome in children after split liver transplantation.

      Hak JF, Dabadie A, Hery G, Aschero A, Desvignes C, Pico H, Roquelaure B, Delarue A, Bourliere B, Colavolpe N, Gorincour G, Auquier P, Petit P.

      Diagn Interv Imaging. 2018 May 28. pii: S2211-5684(18)30117-7. doi: 10.1016/j.diii.2018.04.012. [Epub ahead of print]

      2. Comparison of retrievable stents and permanent stents for Budd-Chiari syndrome due to obstructive inferior vena cava.

      Bi Y, Chen H, Ding P, Ren J, Han X.

      J Gastroenterol Hepatol. 2018 May 30. doi: 10.1111/jgh.14295. [Epub ahead of print]

      3. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study.

      Wang HW, Shi HN, Cheng J, Xie F, Luo YK, Tang J.

      PLoS One. 2018 May 30;13(5):e0197550. doi: 10.1371/journal.pone.0197550. eCollection 2018.

      4. Hepatocellular nodules in vascular liver diseases.

      Sempoux C, Balabaud C, Paradis V, Bioulac-Sage P.

      Virchows Arch. 2018 May 26. doi: 10.1007/s00428-018-2373-6. [Epub ahead of print] Review.

      5. The epidemiology of Budd-Chiari syndrome in France.

      Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-Carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc’h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-Khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A; French Network for Vascular Disorders of the Liver.

      Dig Liver Dis. 2018 Apr 12. pii: S1590-8658(18)30701-1. doi: 10.1016/j.dld.2018.04.004. [Epub ahead of print]

      6. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.

      Li M, De Stefano V, Song T, Zhou X, Guo Z, Zhu J, Qi X.

      Thromb Res. 2018 May 8;167:96-103. doi: 10.1016/j.thromres.2018.05.007. [Epub ahead of print] Review.

      7. The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome.

      Guan ZY, Yu CW, Song T, Gao Y.

      Eur Rev Med Pharmacol Sci. 2018 May;22(9):2742-2750. doi: 10.26355/eurrev_201805_14971.

      8. Erythrocytes from patients with myeloproliferative neoplasms and splanchnic venous thrombosis show greater expression of Lu/BCAM.

      Novitzky-Basso I, Spring F, Anstee D, Tripathi D, Chen F.

      Int J Lab Hematol. 2018 May 13. doi: 10.1111/ijlh.12838. [Epub ahead of print]

      9. Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?

      Mancuso A.

      Eur J Vasc Endovasc Surg. 2018 May 3. pii: S1078-5884(18)30207-7. doi: 10.1016/j.ejvs.2018.03.033. [Epub ahead of print] No abstract available.

      10. New Left Lobe Transplantation Procedure with Caval Reconstruction Using an Inverted Composite Graft for Chronic Budd-Chiari Syndrome in Living-Donor Liver Transplantation-A Case Report.

      Yagi T, Takagi K, Yoshida R, Umeda Y, Nobuoka D, Kuise T, Fujiwara T, Takaki A.

      Transplant Proc. 2018 May;50(4):1192-1195. doi: 10.1016/j.transproceed.2017.11.078.

      11. Is Hepatovenocaval Syndrome a Different Entity from Budd-Chiari Syndrome in Children?

      Waheed N, Cheema HA, Suleman H, Mushtaq I, Fayyaz Z, Anjum N.

      J Coll Physicians Surg Pak. 2018 May;28(5):344-347. doi: 10.29271/jcpsp.2018.05.344.

      12. Prothrombin gene mutation in Budd-Chiari syndrome-The first case report from India.

      Jain A, Shukla A.

      Indian J Gastroenterol. 2018 Mar;37(2):174-175. doi: 10.1007/s12664-018-0845-x. Epub 2018 Apr 4. No abstract available.

      13. Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis.

      Mikuła T, Kozłowska J, Stańczak W, Sapuła M, Różyk A, Wiercińska-Drapało A.

      Gastroenterol Res Pract. 2018 Apr 18;2018:3287491. doi: 10.1155/2018/3287491. eCollection 2018.

      14. Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience.

      Miura K, Sugawara Y, Uchida K, Kawabata S, Yoshii D, Isono K, Hayashida S, Ohya Y, Yamamoto H, Kobayashi T, Wakai T, Inomata Y, Hibi T.

      Transplant Direct. 2018 Apr 13;4(5):e341. doi: 10.1097/TXD.0000000000000780. eCollection 2018 May.

      15. Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.

      Jha RC, Khera SS, Kalaria AD.

      AJR Am J Roentgenol. 2018 May 24:1-11. doi: 10.2214/AJR.18.19548. [Epub ahead of print]

      16. Thrombotic and Hemorrhagic Complications during Visceral Transplantation: Risk factors, and Association with Intraoperative Disseminated Intravascular Coagulation-like Thromboelastographic Qualities: Single Center Retrospective Study.

      Raveh Y, Rodriguez Y, Pretto E, Souki F, Shatz V, Ashrafi B, Manmohansigh V, Demos M, Livingstone J, Nasrallah G, Andrews D, Beduschi T, Vianna R, Nicolau-Raducu R.

      Transpl Int. 2018 May 22. doi: 10.1111/tri.13281. [Epub ahead of print]

      16. Transsplenic splenoportography and portal venous interventions in pediatric patients.

      Monroe EJ, Speir EJ, Hawkins CM, Shivaram G, Koo KSH, Gill AE.

      Pediatr Radiol. 2018 May 13. doi: 10.1007/s00247-018-4157-1. [Epub ahead of print]

      17. Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals.

      Russo FP, Zanetto A, Campello E, Bulato C, Shalaby S, Spiezia L, Gavasso S, Franceschet E, Radu C, Senzolo M, Burra P, Lisman T, Simioni P.

      Liver Int. 2018 May 8. doi: 10.1111/liv.13873. [Epub ahead of print]

      18. Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.

      Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Aguilar-Olivos NE, Alva-López LF, Fajardo-Ordoñez E, Ponciano-Rodríguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, Méndez-Sánchez N.

      Ann Hepatol. 2018 May-June;17(3):476-481. doi: 10.5604/01.3001.0011.7392.

      19. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

      Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN.

      Ann Gastroenterol. 2018 May-Jun;31(3):315-329. doi: 10.20524/aog.2018.0245. Epub 2018 Mar 3. Review.

      20. Perioperative anticoagulation practices for pediatric liver transplantation.

      Voulgarelis S, Vitola B, Lerret SM, Hong JC, Scott JP.

      Pediatr Transplant. 2018 Apr 16:e13193. doi: 10.1111/petr.13193. [Epub ahead of print]

      21. Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.

      Akpan IJ, Stein BL.

      Curr Hematol Malig Rep. 2018 Apr 11. doi: 10.1007/s11899-018-0446-x

Viewing 0 reply threads
  • You must be logged in to reply to this topic.